Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacy
Keywords: لیامایسین; EGFR; epidermal growth factor receptor; MMPs; matrix metalloproteinases; Ec; EGF derived oligopeptide; TIMP2; tissue inhibitor of matrix metalloproteinase 2; LDM; lidamycin; LDP; lidamycin apoprotein; AE; active enediyne; NSCLC; non-small-cell lung carcin